Cognex Corporation (CGNX)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Cognex Corporation (CGNX) trades at $48.86 with AI Score 58/100 (Hold). Cognex Corporation is a global leader in machine vision, providing solutions that automate manufacturing and distribution processes. Market cap: 9B, Sector: Technology.
Last analyzed: Feb 6, 2026Cognex Corporation (CGNX) Technology Profile & Competitive Position
Cognex Corporation, a pioneer in machine vision, offers cutting-edge solutions for automation across diverse industries, driving efficiency and quality with a robust product portfolio and established market presence, making it a compelling investment in the future of smart manufacturing and logistics.
Investment Thesis
Cognex presents a notable research candidate due to its leading position in the growing machine vision market. The company's innovative solutions cater to the increasing demand for automation across diverse industries, driven by the need for enhanced efficiency and quality control. With a solid gross margin of 67.6% and a profit margin of 11.3%, Cognex demonstrates strong financial performance. Key growth catalysts include expanding applications of machine vision in logistics, pharmaceuticals, and electric vehicles. The company's established brand, extensive product portfolio, and global reach provide a competitive edge. While the P/E ratio of 64.62 is relatively high, it reflects the market's expectation of future growth. The dividend yield of 0.77% offers a modest income component. Investing in Cognex allows exposure to the long-term trend of automation and digitalization in manufacturing and distribution.
Based on FMP financials and quantitative analysis
Key Highlights
- Market Cap of $7.11B reflects Cognex's strong position in the machine vision market.
- P/E Ratio of 64.62 indicates investor expectations of future growth potential.
- Gross Margin of 67.6% highlights efficient operations and strong pricing power.
- Profit Margin of 11.3% demonstrates the company's ability to convert revenue into profit.
- Dividend Yield of 0.77% provides a modest income stream for investors.
Competitors & Peers
Strengths
- Leading market share in machine vision.
- Strong brand recognition and reputation.
- Diverse product portfolio serving multiple industries.
- Innovative technology and proprietary software.
Weaknesses
- High P/E ratio compared to industry peers.
- Dependence on cyclical industries such as automotive and electronics.
- Exposure to global economic fluctuations.
- Potential impact from currency exchange rates.
Catalysts
- Ongoing: Increasing adoption of automation in manufacturing and logistics.
- Upcoming: New product launches featuring advanced deep learning capabilities.
- Ongoing: Expansion into emerging markets with high growth potential.
- Upcoming: Potential acquisitions of complementary businesses or technologies.
Risks
- Potential: Economic downturns impacting capital spending by manufacturers.
- Ongoing: Intense competition from established players and new entrants.
- Potential: Rapid technological advancements rendering existing products obsolete.
- Ongoing: Disruptions in the global supply chain.
- Potential: Fluctuations in currency exchange rates impacting profitability.
Growth Opportunities
- Expanding into Logistics Automation: The e-commerce boom is driving demand for automated warehousing and logistics solutions. Cognex can capitalize on this trend by offering machine vision systems for package sorting, tracking, and inspection. The global warehouse automation market is projected to reach $30 billion by 2027, presenting a significant growth opportunity for Cognex. This expansion leverages Cognex's existing technology and expertise in image-based barcode reading and verification.
- Penetrating the Pharmaceutical and Medical Device Industries: Stringent quality control requirements in the pharmaceutical and medical device industries create a strong demand for machine vision solutions. Cognex can expand its presence in these sectors by offering systems for drug inspection, medical device assembly verification, and regulatory compliance. This market segment offers high margins and long-term growth potential, aligning with Cognex's focus on high-value applications.
- Capitalizing on the Growth of Electric Vehicle Manufacturing: The rapid growth of the electric vehicle (EV) market is creating new opportunities for machine vision in battery manufacturing, assembly, and quality control. Cognex can leverage its expertise in precision inspection and robotic guidance to provide solutions for EV manufacturers. The EV market is expected to grow exponentially in the coming years, driving demand for Cognex's products.
- Developing Advanced Deep Learning Vision Software: Cognex can further enhance its competitive advantage by investing in the development of advanced deep learning vision software. This technology enables machine vision systems to perform more complex tasks, such as defect detection and object recognition, with greater accuracy and efficiency. By offering cutting-edge deep learning solutions, Cognex can attract new customers and expand its market share.
- Expanding Global Reach in Emerging Markets: Cognex can drive growth by expanding its presence in emerging markets, such as China, India, and Southeast Asia. These regions are experiencing rapid industrialization and increasing adoption of automation technologies. By establishing local sales and support networks, Cognex can effectively serve customers in these markets and capitalize on their growth potential.
Opportunities
- Expanding into new applications such as logistics and healthcare.
- Capitalizing on the growth of automation in emerging markets.
- Developing advanced deep learning vision software.
- Acquiring complementary technologies and businesses.
Threats
- Intense competition from established players and new entrants.
- Rapid technological advancements potentially rendering existing products obsolete.
- Economic slowdowns impacting capital spending by manufacturers.
- Disruptions in the global supply chain.
Competitive Advantages
- Strong brand reputation and established market leadership.
- Extensive product portfolio catering to diverse applications.
- Proprietary software and algorithms providing a technological edge.
- Global sales and support network ensuring customer satisfaction.
About CGNX
Cognex Corporation, founded in 1981 and headquartered in Natick, Massachusetts, stands as a global leader in the field of machine vision. The company's core business revolves around developing and providing machine vision products that capture and analyze visual information, enabling the automation of manufacturing and distribution tasks worldwide. These products are instrumental in automating the manufacturing and tracking of discrete items, ranging from mobile phones to automobile tires, by precisely locating, identifying, inspecting, and measuring them during production and distribution processes. Cognex offers a comprehensive suite of software solutions, including VisionPro, a patented vision tool for advanced programming, QuickBuild, which allows customers to construct vision applications using a graphical, flowchart-based interface, and Cognex deep learning vision software. Cognex's product portfolio encompasses a wide array of inspection tasks, such as part location, identification, measurement, assembly verification, and robotic guidance. The company also provides vision sensors tailored for specific vision applications, including checking the presence and size of parts, as well as the In-Sight product line of vision systems and sensors. Furthermore, Cognex offers DataMan, an image-based barcode reader and barcode verifier. Cognex serves a diverse range of industries, including consumer electronics, automotive, consumer products, food and beverage, pharmaceuticals, and medical devices, reaching customers through a network of distributors and integrators. With a market capitalization of $7.11 billion, Cognex has established itself as a key player in the machine vision market, driving innovation and automation across various sectors.
What They Do
- Develops and provides machine vision systems.
- Creates software for analyzing visual information.
- Automates manufacturing and distribution tasks.
- Offers solutions for locating, identifying, inspecting, and measuring discrete items.
- Provides image-based barcode readers and verifiers.
- Serves industries including consumer electronics, automotive, and pharmaceuticals.
Business Model
- Sells machine vision systems and sensors.
- Generates revenue from software licenses and maintenance agreements.
- Provides services such as training and consulting.
- Distributes products through a network of distributors and integrators.
Industry Context
Cognex operates in the machine vision market, which is experiencing significant growth driven by the increasing adoption of automation in manufacturing, logistics, and healthcare. The industry is characterized by technological advancements, such as deep learning and artificial intelligence, which are enhancing the capabilities of machine vision systems. Cognex competes with companies like Balluff (BMI), Datalogic S.p.A. (DSGX), ESE S.p.A. (ESE), Littelfuse, Inc. (LFUS), and Novanta Inc. (NOVT), each offering various machine vision solutions. The market is expected to continue growing as companies seek to improve efficiency, reduce costs, and enhance product quality through automation.
Key Customers
- Consumer electronics manufacturers
- Automotive companies
- Food and beverage producers
- Pharmaceutical and medical device companies
Financials
Chart & Info
Cognex Corporation (CGNX) stock price: $48.86 (-0.48, -0.97%)
Latest News
-
Assenagon Asset Management S.A. Reduces Stock Position in Cognex Corporation $CGNX
defenseworld.net · Apr 1, 2026
-
CGNX: Lowering target price to $51.00
Argus Research · Apr 1, 2026
-
Benchmark, Plexus, Amphenol, EchoStar, and Cognex Shares Are Falling, What You Need To Know
Yahoo! Finance: CGNX News · Mar 31, 2026
-
1 Cash-Producing Stock on Our Buy List and 2 We Avoid
Yahoo! Finance: CGNX News · Mar 30, 2026
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CGNX.
Price Targets
Consensus target: $62.00
MoonshotScore
What does this score mean?
The MoonshotScore rates CGNX's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Classification
Industry Hardware, Equipment & PartsCompetitors & Peers
Latest News
Assenagon Asset Management S.A. Reduces Stock Position in Cognex Corporation $CGNX
CGNX: Lowering target price to $51.00
Benchmark, Plexus, Amphenol, EchoStar, and Cognex Shares Are Falling, What You Need To Know
1 Cash-Producing Stock on Our Buy List and 2 We Avoid
Common Questions About CGNX
What does Cognex Corporation do?
Cognex Corporation is the world's leading provider of machine vision systems, sensors, and software used in automated manufacturing and distribution. Their products capture and analyze visual information to automate tasks such as inspection, guidance, and identification. Cognex's solutions are used across a wide range of industries, including automotive, electronics, pharmaceuticals, and logistics, to improve product quality, reduce costs, and increase efficiency. The company's innovative technology and global presence have established it as a key enabler of automation and Industry 4.0.
Is CGNX stock worth researching?
CGNX stock presents a mixed investment picture. The company's strong market position, innovative technology, and growth potential in automation make it attractive. However, the high P/E ratio of 64.62 suggests that the stock may be overvalued. Investors may want to evaluate the company's growth prospects, competitive landscape, and potential risks before making a decision. A balanced approach would involve assessing the company's long-term growth potential against its current valuation and risk factors.
What are the main risks for CGNX?
The main risks for Cognex include economic downturns impacting capital spending by manufacturers, intense competition from established players and new entrants, and rapid technological advancements rendering existing products obsolete. Additionally, disruptions in the global supply chain and fluctuations in currency exchange rates could negatively impact the company's profitability. Investors should carefully consider these risks when evaluating CGNX stock.
What are the key factors to evaluate for CGNX?
Cognex Corporation (CGNX) currently holds an AI score of 58/100, indicating moderate score. The stock trades at a P/E of 71.2x, above the S&P 500 average (~20-25x), suggesting high growth expectations. Analysts target $62.00 (+27% from $48.86). Key strength: Leading market share in machine vision.. Primary risk to monitor: Potential: Economic downturns impacting capital spending by manufacturers.. This is not financial advice.
How frequently does CGNX data refresh on this page?
CGNX prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven CGNX's recent stock price performance?
Recent price movement in Cognex Corporation (CGNX) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. The current analyst target of $62.00 implies 27% upside from here. Notable catalyst: Leading market share in machine vision.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider CGNX overvalued or undervalued right now?
Determining whether Cognex Corporation (CGNX) is overvalued or undervalued requires examining multiple metrics. Its P/E ratio is 71.2. Analysts target $62.00 (+27% from current price), suggesting analysts see upside potential. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying CGNX?
Before investing in Cognex Corporation (CGNX), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data and may be subject to change.
- Investment decisions should be based on individual risk tolerance and financial circumstances.